SANN — Santhera Pharmaceuticals Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣163.59m
- CH₣163.29m
- CH₣39.12m
Annual cashflow statement for Santhera Pharmaceuticals Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -67.5 | -54.7 | -70.6 | 54.8 | -41.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.34 | -19.4 | 4.18 | -19.2 | 7.19 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.5 | 33 | 26.7 | 8.64 | -6.7 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -43.5 | -37.4 | -29.8 | 47.3 | -35.5 |
| Capital Expenditures | -0.034 | -0.015 | -3.96 | -23.7 | -0.151 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.6 | 0.084 | 0.024 | 5.7 | 0.09 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.56 | 0.069 | -3.93 | -18 | -0.061 |
| Financing Cash Flow Items | -0.317 | -5.83 | -0.426 | -0.304 | 24.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.1 | 46 | 14 | -0.171 | 46.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -18.9 | 8.8 | -19.9 | 29 | 10.6 |